The global market for Unfractionated Heparin Sodium API was valued at US$ 775 million in the year 2024 and is projected to reach a revised size of US$ 1484 million by 2031, growing at a CAGR of 8.1% during the forecast period.

$Unfractionated Heparin Sodium API Market$

Unfractionated Heparin Sodium API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Unfractionated Heparin Sodium API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Unfractionated Heparin Sodium API is a natural polysaccharide-based anticoagulant active pharmaceutical ingredient extracted and purified from porcine intestinal mucosa or other animal tissues. It consists primarily of sodium heparin with a broad molecular weight distribution, averaging 12,000–15,000 Da. Its anticoagulant activity is exerted by enhancing antithrombin III (ATIII) activity, which inhibits thrombin and factor Xa. As the raw material for unfractionated heparin injections, flush solutions, and other anticoagulant formulations, unfractionated heparin sodium is widely used in hemodialysis, extracorporeal circulation, cardiac surgery, thrombosis prevention, and treatment, making it an essential API in clinical anticoagulant therapy.In 2024, global Unfractionated Heparin Sodium API production reached approximately 19296 billion units, with an average global market price of around US$ 40156 per billion unit.

North American market for Unfractionated Heparin Sodium API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Unfractionated Heparin Sodium API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Unfractionated Heparin Sodium API include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Unfractionated Heparin Sodium API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Unfractionated Heparin Sodium API.

The Unfractionated Heparin Sodium API market size, estimations, and forecasts are provided in terms of output/shipments (Billion Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Unfractionated Heparin Sodium API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Unfractionated Heparin Sodium API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Unfractionated Heparin Sodium API Market Report

Report Metric	Details
Report Name	Unfractionated Heparin Sodium API Market
Accounted market size in year	US$ 775 million
Forecasted market size in 2031	US$ 1484 million
CAGR	8.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	USP Grade EP Grade Other
Segment by Application	Cardiovascular Disease Dialysis Anticoagulation Postoperative Thrombosis Prevention Other
Production by Region	North America Europe China India
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, Aspen Oss, Yino Pharma, Nanjing Xinbai Pharmaceutical, Hubei Enoray Biopharmaceutical, Cisen Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Unfractionated Heparin Sodium API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Unfractionated Heparin Sodium API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Unfractionated Heparin Sodium API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Unfractionated Heparin Sodium API Market growing?

Ans: The Unfractionated Heparin Sodium API Market witnessing a CAGR of 8.1% during the forecast period 2025-2031.

What is the Unfractionated Heparin Sodium API Market size in 2031?

Ans: The Unfractionated Heparin Sodium API Market size in 2031 will be US$ 1484 million.

Who are the main players in the Unfractionated Heparin Sodium API Market report?

Ans: The main players in the Unfractionated Heparin Sodium API Market are Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, Aspen Oss, Yino Pharma, Nanjing Xinbai Pharmaceutical, Hubei Enoray Biopharmaceutical, Cisen Pharmaceutical

What are the Application segmentation covered in the Unfractionated Heparin Sodium API Market report?

Ans: The Applications covered in the Unfractionated Heparin Sodium API Market report are Cardiovascular Disease, Dialysis Anticoagulation, Postoperative Thrombosis Prevention, Other

What are the Type segmentation covered in the Unfractionated Heparin Sodium API Market report?

Ans: The Types covered in the Unfractionated Heparin Sodium API Market report are USP Grade, EP Grade, Other

1 Unfractionated Heparin Sodium API Market Overview

1.1 Product Definition

1.2 Unfractionated Heparin Sodium API by Type

1.2.1 Global Unfractionated Heparin Sodium API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 USP Grade

1.2.3 EP Grade

1.2.4 Other

1.3 Unfractionated Heparin Sodium API by Application

1.3.1 Global Unfractionated Heparin Sodium API Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Cardiovascular Disease

1.3.3 Dialysis Anticoagulation

1.3.4 Postoperative Thrombosis Prevention

1.3.5 Other

1.4 Global Market Growth Prospects

1.4.1 Global Unfractionated Heparin Sodium API Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Unfractionated Heparin Sodium API Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Unfractionated Heparin Sodium API Production Estimates and Forecasts (2020-2031)

1.4.4 Global Unfractionated Heparin Sodium API Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Unfractionated Heparin Sodium API Production Market Share by Manufacturers (2020-2025)

2.2 Global Unfractionated Heparin Sodium API Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Unfractionated Heparin Sodium API, Industry Ranking, 2023 VS 2024

2.4 Global Unfractionated Heparin Sodium API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Unfractionated Heparin Sodium API Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Unfractionated Heparin Sodium API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Unfractionated Heparin Sodium API, Product Offered and Application

2.8 Global Key Manufacturers of Unfractionated Heparin Sodium API, Date of Enter into This Industry

2.9 Unfractionated Heparin Sodium API Market Competitive Situation and Trends

2.9.1 Unfractionated Heparin Sodium API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Unfractionated Heparin Sodium API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Unfractionated Heparin Sodium API Production by Region

3.1 Global Unfractionated Heparin Sodium API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Unfractionated Heparin Sodium API Production Value by Region (2020-2031)

3.2.1 Global Unfractionated Heparin Sodium API Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Unfractionated Heparin Sodium API by Region (2026-2031)

3.3 Global Unfractionated Heparin Sodium API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Unfractionated Heparin Sodium API Production Volume by Region (2020-2031)

3.4.1 Global Unfractionated Heparin Sodium API Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Unfractionated Heparin Sodium API by Region (2026-2031)

3.5 Global Unfractionated Heparin Sodium API Market Price Analysis by Region (2020-2025)

3.6 Global Unfractionated Heparin Sodium API Production and Value, Year-over-Year Growth

3.6.1 North America Unfractionated Heparin Sodium API Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Unfractionated Heparin Sodium API Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Unfractionated Heparin Sodium API Production Value Estimates and Forecasts (2020-2031)

3.6.4 India Unfractionated Heparin Sodium API Production Value Estimates and Forecasts (2020-2031)

4 Unfractionated Heparin Sodium API Consumption by Region

4.1 Global Unfractionated Heparin Sodium API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Unfractionated Heparin Sodium API Consumption by Region (2020-2031)

4.2.1 Global Unfractionated Heparin Sodium API Consumption by Region (2020-2025)

4.2.2 Global Unfractionated Heparin Sodium API Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Unfractionated Heparin Sodium API Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Unfractionated Heparin Sodium API Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Unfractionated Heparin Sodium API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Unfractionated Heparin Sodium API Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Unfractionated Heparin Sodium API Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Unfractionated Heparin Sodium API Production by Type (2020-2031)

5.1.1 Global Unfractionated Heparin Sodium API Production by Type (2020-2025)

5.1.2 Global Unfractionated Heparin Sodium API Production by Type (2026-2031)

5.1.3 Global Unfractionated Heparin Sodium API Production Market Share by Type (2020-2031)

5.2 Global Unfractionated Heparin Sodium API Production Value by Type (2020-2031)

5.2.1 Global Unfractionated Heparin Sodium API Production Value by Type (2020-2025)

5.2.2 Global Unfractionated Heparin Sodium API Production Value by Type (2026-2031)

5.2.3 Global Unfractionated Heparin Sodium API Production Value Market Share by Type (2020-2031)

5.3 Global Unfractionated Heparin Sodium API Price by Type (2020-2031)

6 Segment by Application

6.1 Global Unfractionated Heparin Sodium API Production by Application (2020-2031)

6.1.1 Global Unfractionated Heparin Sodium API Production by Application (2020-2025)

6.1.2 Global Unfractionated Heparin Sodium API Production by Application (2026-2031)

6.1.3 Global Unfractionated Heparin Sodium API Production Market Share by Application (2020-2031)

6.2 Global Unfractionated Heparin Sodium API Production Value by Application (2020-2031)

6.2.1 Global Unfractionated Heparin Sodium API Production Value by Application (2020-2025)

6.2.2 Global Unfractionated Heparin Sodium API Production Value by Application (2026-2031)

6.2.3 Global Unfractionated Heparin Sodium API Production Value Market Share by Application (2020-2031)

6.3 Global Unfractionated Heparin Sodium API Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Shenzhen Hepalink Pharmaceutical

7.1.1 Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Company Information

7.1.2 Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio

7.1.3 Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Shenzhen Hepalink Pharmaceutical Main Business and Markets Served

7.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates

7.2 Yantai Dongcheng Pharmaceutical

7.2.1 Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Company Information

7.2.2 Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio

7.2.3 Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Yantai Dongcheng Pharmaceutical Main Business and Markets Served

7.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates

7.3 Pfizer

7.3.1 Pfizer Unfractionated Heparin Sodium API Company Information

7.3.2 Pfizer Unfractionated Heparin Sodium API Product Portfolio

7.3.3 Pfizer Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Pfizer Main Business and Markets Served

7.3.5 Pfizer Recent Developments/Updates

7.4 Bioibérica

7.4.1 Bioibérica Unfractionated Heparin Sodium API Company Information

7.4.2 Bioibérica Unfractionated Heparin Sodium API Product Portfolio

7.4.3 Bioibérica Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Bioibérica Main Business and Markets Served

7.4.5 Bioibérica Recent Developments/Updates

7.5 Changzhou Qianhong Biopharma

7.5.1 Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Company Information

7.5.2 Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Product Portfolio

7.5.3 Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Changzhou Qianhong Biopharma Main Business and Markets Served

7.5.5 Changzhou Qianhong Biopharma Recent Developments/Updates

7.6 Nanjing King-friend Biochemical Pharmaceutical

7.6.1 Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Company Information

7.6.2 Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio

7.6.3 Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Nanjing King-friend Biochemical Pharmaceutical Main Business and Markets Served

7.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates

7.7 Hebei Changshan Biochemical Pharmaceutical

7.7.1 Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Company Information

7.7.2 Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio

7.7.3 Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served

7.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates

7.8 Qingdao Jiulong Biopharmaceutical

7.8.1 Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Company Information

7.8.2 Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Product Portfolio

7.8.3 Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Qingdao Jiulong Biopharmaceutical Main Business and Markets Served

7.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates

7.9 Opocrin

7.9.1 Opocrin Unfractionated Heparin Sodium API Company Information

7.9.2 Opocrin Unfractionated Heparin Sodium API Product Portfolio

7.9.3 Opocrin Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Opocrin Main Business and Markets Served

7.9.5 Opocrin Recent Developments/Updates

7.10 Dongying Tiandong Pharmaceutical

7.10.1 Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Company Information

7.10.2 Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio

7.10.3 Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Dongying Tiandong Pharmaceutical Main Business and Markets Served

7.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates

7.11 Aspen Oss

7.11.1 Aspen Oss Unfractionated Heparin Sodium API Company Information

7.11.2 Aspen Oss Unfractionated Heparin Sodium API Product Portfolio

7.11.3 Aspen Oss Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Aspen Oss Main Business and Markets Served

7.11.5 Aspen Oss Recent Developments/Updates

7.12 Yino Pharma

7.12.1 Yino Pharma Unfractionated Heparin Sodium API Company Information

7.12.2 Yino Pharma Unfractionated Heparin Sodium API Product Portfolio

7.12.3 Yino Pharma Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Yino Pharma Main Business and Markets Served

7.12.5 Yino Pharma Recent Developments/Updates

7.13 Nanjing Xinbai Pharmaceutical

7.13.1 Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Company Information

7.13.2 Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio

7.13.3 Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.13.4 Nanjing Xinbai Pharmaceutical Main Business and Markets Served

7.13.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates

7.14 Hubei Enoray Biopharmaceutical

7.14.1 Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Company Information

7.14.2 Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Product Portfolio

7.14.3 Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.14.4 Hubei Enoray Biopharmaceutical Main Business and Markets Served

7.14.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates

7.15 Cisen Pharmaceutical

7.15.1 Cisen Pharmaceutical Unfractionated Heparin Sodium API Company Information

7.15.2 Cisen Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio

7.15.3 Cisen Pharmaceutical Unfractionated Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)

7.15.4 Cisen Pharmaceutical Main Business and Markets Served

7.15.5 Cisen Pharmaceutical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Unfractionated Heparin Sodium API Industry Chain Analysis

8.2 Unfractionated Heparin Sodium API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Unfractionated Heparin Sodium API Production Mode & Process Analysis

8.4 Unfractionated Heparin Sodium API Sales and Marketing

8.4.1 Unfractionated Heparin Sodium API Sales Channels

8.4.2 Unfractionated Heparin Sodium API Distributors

8.5 Unfractionated Heparin Sodium API Customer Analysis

9 Unfractionated Heparin Sodium API Market Dynamics

9.1 Unfractionated Heparin Sodium API Industry Trends

9.2 Unfractionated Heparin Sodium API Market Drivers

9.3 Unfractionated Heparin Sodium API Market Challenges

9.4 Unfractionated Heparin Sodium API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Shenzhen Hepalink Pharmaceutical

Yantai Dongcheng Pharmaceutical

Pfizer Inc

Bioibérica

Changzhou Qianhong Biopharma

Nanjing King-friend Biochemical Pharmaceutical

Hebei Changshan Biochemical Pharmaceutical

Qingdao Jiulong Biopharmaceutical

Opocrin

Dongying Tiandong Pharmaceutical

Aspen Oss

Yino Pharma

Nanjing Xinbai Pharmaceutical

Hubei Enoray Biopharmaceutical

Cisen Pharmaceutical

List of Tables

Table 1. Global Unfractionated Heparin Sodium API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Unfractionated Heparin Sodium API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Unfractionated Heparin Sodium API Production Capacity (Billion Units) by Manufacturers in 2024

Table 4. Global Unfractionated Heparin Sodium API Production by Manufacturers (2020-2025) & (Billion Units)

Table 5. Global Unfractionated Heparin Sodium API Production Market Share by Manufacturers (2020-2025)

Table 6. Global Unfractionated Heparin Sodium API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Unfractionated Heparin Sodium API Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Unfractionated Heparin Sodium API, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Unfractionated Heparin Sodium API as of 2024)

Table 10. Global Market Unfractionated Heparin Sodium API Average Price by Manufacturers (US$/Billion Unit) & (2020-2025)

Table 11. Global Key Manufacturers of Unfractionated Heparin Sodium API, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Unfractionated Heparin Sodium API, Product Offered and Application

Table 13. Global Key Manufacturers of Unfractionated Heparin Sodium API, Date of Enter into This Industry

Table 14. Global Unfractionated Heparin Sodium API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Unfractionated Heparin Sodium API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Unfractionated Heparin Sodium API Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Unfractionated Heparin Sodium API Production Value Market Share by Region (2020-2025)

Table 19. Global Unfractionated Heparin Sodium API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Unfractionated Heparin Sodium API Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Unfractionated Heparin Sodium API Production Comparison by Region: 2020 VS 2024 VS 2031 (Billion Units)

Table 22. Global Unfractionated Heparin Sodium API Production (Billion Units) by Region (2020-2025)

Table 23. Global Unfractionated Heparin Sodium API Production Market Share by Region (2020-2025)

Table 24. Global Unfractionated Heparin Sodium API Production (Billion Units) Forecast by Region (2026-2031)

Table 25. Global Unfractionated Heparin Sodium API Production Market Share Forecast by Region (2026-2031)

Table 26. Global Unfractionated Heparin Sodium API Market Average Price (US$/Billion Unit) by Region (2020-2025)

Table 27. Global Unfractionated Heparin Sodium API Market Average Price (US$/Billion Unit) by Region (2026-2031)

Table 28. Global Unfractionated Heparin Sodium API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Billion Units)

Table 29. Global Unfractionated Heparin Sodium API Consumption by Region (2020-2025) & (Billion Units)

Table 30. Global Unfractionated Heparin Sodium API Consumption Market Share by Region (2020-2025)

Table 31. Global Unfractionated Heparin Sodium API Forecasted Consumption by Region (2026-2031) & (Billion Units)

Table 32. Global Unfractionated Heparin Sodium API Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Billion Units)

Table 34. North America Unfractionated Heparin Sodium API Consumption by Country (2020-2025) & (Billion Units)

Table 35. North America Unfractionated Heparin Sodium API Consumption by Country (2026-2031) & (Billion Units)

Table 36. Europe Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Billion Units)

Table 37. Europe Unfractionated Heparin Sodium API Consumption by Country (2020-2025) & (Billion Units)

Table 38. Europe Unfractionated Heparin Sodium API Consumption by Country (2026-2031) & (Billion Units)

Table 39. Asia Pacific Unfractionated Heparin Sodium API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Billion Units)

Table 40. Asia Pacific Unfractionated Heparin Sodium API Consumption by Region (2020-2025) & (Billion Units)

Table 41. Asia Pacific Unfractionated Heparin Sodium API Consumption by Region (2026-2031) & (Billion Units)

Table 42. Latin America, Middle East & Africa Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Billion Units)

Table 43. Latin America, Middle East & Africa Unfractionated Heparin Sodium API Consumption by Country (2020-2025) & (Billion Units)

Table 44. Latin America, Middle East & Africa Unfractionated Heparin Sodium API Consumption by Country (2026-2031) & (Billion Units)

Table 45. Global Unfractionated Heparin Sodium API Production (Billion Units) by Type (2020-2025)

Table 46. Global Unfractionated Heparin Sodium API Production (Billion Units) by Type (2026-2031)

Table 47. Global Unfractionated Heparin Sodium API Production Market Share by Type (2020-2025)

Table 48. Global Unfractionated Heparin Sodium API Production Market Share by Type (2026-2031)

Table 49. Global Unfractionated Heparin Sodium API Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Unfractionated Heparin Sodium API Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Unfractionated Heparin Sodium API Production Value Market Share by Type (2020-2025)

Table 52. Global Unfractionated Heparin Sodium API Production Value Market Share by Type (2026-2031)

Table 53. Global Unfractionated Heparin Sodium API Price (US$/Billion Unit) by Type (2020-2025)

Table 54. Global Unfractionated Heparin Sodium API Price (US$/Billion Unit) by Type (2026-2031)

Table 55. Global Unfractionated Heparin Sodium API Production (Billion Units) by Application (2020-2025)

Table 56. Global Unfractionated Heparin Sodium API Production (Billion Units) by Application (2026-2031)

Table 57. Global Unfractionated Heparin Sodium API Production Market Share by Application (2020-2025)

Table 58. Global Unfractionated Heparin Sodium API Production Market Share by Application (2026-2031)

Table 59. Global Unfractionated Heparin Sodium API Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Unfractionated Heparin Sodium API Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Unfractionated Heparin Sodium API Production Value Market Share by Application (2020-2025)

Table 62. Global Unfractionated Heparin Sodium API Production Value Market Share by Application (2026-2031)

Table 63. Global Unfractionated Heparin Sodium API Price (US$/Billion Unit) by Application (2020-2025)

Table 64. Global Unfractionated Heparin Sodium API Price (US$/Billion Unit) by Application (2026-2031)

Table 65. Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Company Information

Table 66. Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Specification and Application

Table 67. Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 68. Shenzhen Hepalink Pharmaceutical Main Business and Markets Served

Table 69. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates

Table 70. Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Company Information

Table 71. Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Specification and Application

Table 72. Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 73. Yantai Dongcheng Pharmaceutical Main Business and Markets Served

Table 74. Yantai Dongcheng Pharmaceutical Recent Developments/Updates

Table 75. Pfizer Unfractionated Heparin Sodium API Company Information

Table 76. Pfizer Unfractionated Heparin Sodium API Specification and Application

Table 77. Pfizer Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Main Business and Markets Served

Table 79. Pfizer Recent Developments/Updates

Table 80. Bioibérica Unfractionated Heparin Sodium API Company Information

Table 81. Bioibérica Unfractionated Heparin Sodium API Specification and Application

Table 82. Bioibérica Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 83. Bioibérica Main Business and Markets Served

Table 84. Bioibérica Recent Developments/Updates

Table 85. Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Company Information

Table 86. Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Specification and Application

Table 87. Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 88. Changzhou Qianhong Biopharma Main Business and Markets Served

Table 89. Changzhou Qianhong Biopharma Recent Developments/Updates

Table 90. Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Company Information

Table 91. Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Specification and Application

Table 92. Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 93. Nanjing King-friend Biochemical Pharmaceutical Main Business and Markets Served

Table 94. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates

Table 95. Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Company Information

Table 96. Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Specification and Application

Table 97. Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 98. Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served

Table 99. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates

Table 100. Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Company Information

Table 101. Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Specification and Application

Table 102. Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 103. Qingdao Jiulong Biopharmaceutical Main Business and Markets Served

Table 104. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates

Table 105. Opocrin Unfractionated Heparin Sodium API Company Information

Table 106. Opocrin Unfractionated Heparin Sodium API Specification and Application

Table 107. Opocrin Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 108. Opocrin Main Business and Markets Served

Table 109. Opocrin Recent Developments/Updates

Table 110. Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Company Information

Table 111. Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Specification and Application

Table 112. Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 113. Dongying Tiandong Pharmaceutical Main Business and Markets Served

Table 114. Dongying Tiandong Pharmaceutical Recent Developments/Updates

Table 115. Aspen Oss Unfractionated Heparin Sodium API Company Information

Table 116. Aspen Oss Unfractionated Heparin Sodium API Specification and Application

Table 117. Aspen Oss Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 118. Aspen Oss Main Business and Markets Served

Table 119. Aspen Oss Recent Developments/Updates

Table 120. Yino Pharma Unfractionated Heparin Sodium API Company Information

Table 121. Yino Pharma Unfractionated Heparin Sodium API Specification and Application

Table 122. Yino Pharma Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 123. Yino Pharma Main Business and Markets Served

Table 124. Yino Pharma Recent Developments/Updates

Table 125. Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Company Information

Table 126. Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Specification and Application

Table 127. Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 128. Nanjing Xinbai Pharmaceutical Main Business and Markets Served

Table 129. Nanjing Xinbai Pharmaceutical Recent Developments/Updates

Table 130. Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Company Information

Table 131. Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Specification and Application

Table 132. Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 133. Hubei Enoray Biopharmaceutical Main Business and Markets Served

Table 134. Hubei Enoray Biopharmaceutical Recent Developments/Updates

Table 135. Cisen Pharmaceutical Unfractionated Heparin Sodium API Company Information

Table 136. Cisen Pharmaceutical Unfractionated Heparin Sodium API Specification and Application

Table 137. Cisen Pharmaceutical Unfractionated Heparin Sodium API Production (Billion Units), Value (US$ Million), Price (US$/Billion Unit) and Gross Margin (2020-2025)

Table 138. Cisen Pharmaceutical Main Business and Markets Served

Table 139. Cisen Pharmaceutical Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Unfractionated Heparin Sodium API Distributors List

Table 143. Unfractionated Heparin Sodium API Customers List

Table 144. Unfractionated Heparin Sodium API Market Trends

Table 145. Unfractionated Heparin Sodium API Market Drivers

Table 146. Unfractionated Heparin Sodium API Market Challenges

Table 147. Unfractionated Heparin Sodium API Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Unfractionated Heparin Sodium API

Figure 2. Global Unfractionated Heparin Sodium API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Unfractionated Heparin Sodium API Market Share by Type: 2024 VS 2031

Figure 4. USP Grade Product Picture

Figure 5. EP Grade Product Picture

Figure 6. Other Product Picture

Figure 7. Global Unfractionated Heparin Sodium API Market Value by Application, (US$ Million) & (2020-2031)

Figure 8. Global Unfractionated Heparin Sodium API Market Share by Application: 2024 VS 2031

Figure 9. Application One

Figure 10. Application Two

Figure 11. Application Three

Figure 12. Application Four

Figure 13. Application Five

Figure 14. Application Six

Figure 15. Application Seven

Figure 16. Application Eight

Figure 17. Application Nine

Figure 18. Global Unfractionated Heparin Sodium API Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Unfractionated Heparin Sodium API Production Value (US$ Million) & (2020-2031)

Figure 20. Global Unfractionated Heparin Sodium API Production Capacity (Billion Units) & (2020-2031)

Figure 21. Global Unfractionated Heparin Sodium API Production (Billion Units) & (2020-2031)

Figure 22. Global Unfractionated Heparin Sodium API Average Price (US$/Billion Unit) & (2020-2031)

Figure 23. Unfractionated Heparin Sodium API Report Years Considered

Figure 24. Unfractionated Heparin Sodium API Production Share by Manufacturers in 2024

Figure 25. Global Unfractionated Heparin Sodium API Production Value Share by Manufacturers (2024)

Figure 26. Unfractionated Heparin Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 27. The Global 5 and 10 Largest Players: Market Share by Unfractionated Heparin Sodium API Revenue in 2024

Figure 28. Global Unfractionated Heparin Sodium API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 29. Global Unfractionated Heparin Sodium API Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 30. Global Unfractionated Heparin Sodium API Production Comparison by Region: 2020 VS 2024 VS 2031 (Billion Units)

Figure 31. Global Unfractionated Heparin Sodium API Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 32. North America Unfractionated Heparin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 33. Europe Unfractionated Heparin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 34. China Unfractionated Heparin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 35. India Unfractionated Heparin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 36. Global Unfractionated Heparin Sodium API Consumption by Region: 2020 VS 2024 VS 2031 (Billion Units)

Figure 37. Global Unfractionated Heparin Sodium API Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 38. North America Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 39. North America Unfractionated Heparin Sodium API Consumption Market Share by Country (2020-2031)

Figure 40. U.S. Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 41. Canada Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 42. Europe Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 43. Europe Unfractionated Heparin Sodium API Consumption Market Share by Country (2020-2031)

Figure 44. Germany Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 45. France Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 46. U.K. Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 47. Italy Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 48. Russia Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 49. Asia Pacific Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 50. Asia Pacific Unfractionated Heparin Sodium API Consumption Market Share by Region (2020-2031)

Figure 51. China Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 52. Japan Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 53. South Korea Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 54. China Taiwan Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 55. Southeast Asia Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 56. India Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 57. Latin America, Middle East & Africa Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 58. Latin America, Middle East & Africa Unfractionated Heparin Sodium API Consumption Market Share by Country (2020-2031)

Figure 59. Mexico Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 60. Brazil Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 61. Turkey Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 62. GCC Countries Unfractionated Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Billion Units)

Figure 63. Global Production Market Share of Unfractionated Heparin Sodium API by Type (2020-2031)

Figure 64. Global Production Value Market Share of Unfractionated Heparin Sodium API by Type (2020-2031)

Figure 65. Global Unfractionated Heparin Sodium API Price (US$/Billion Unit) by Type (2020-2031)

Figure 66. Global Production Market Share of Unfractionated Heparin Sodium API by Application (2020-2031)

Figure 67. Global Production Value Market Share of Unfractionated Heparin Sodium API by Application (2020-2031)

Figure 68. Global Unfractionated Heparin Sodium API Price (US$/Billion Unit) by Application (2020-2031)

Figure 69. Unfractionated Heparin Sodium API Value Chain

Figure 70. Channels of Distribution (Direct Vs Distribution)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions